Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging
Completed · Phase 2
Conditions studied: Coronary Disease
In brief
Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI is especially useful when studying the arteries of the heart (CMRA, coronary magnetic resonance angiography). In this study researchers from several laboratories and hospitals will work together to determine the safety and effectiveness of CMRA with MS-325. MS-325 is a contrast agent. It is given to patients undergoing CRMA in order to improve the appearance of the arteries of the heart.
Key facts
- Study ID
- NCT00001633
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
- People needed
- 20
- Starts
- 1997-09-01
- Expected to finish
- 2000-12-01
- Last updated by the study team
- 2008-03-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Heart, Lung and Blood Institute (NHLBI) — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.